Aurora kinase inhibitors are small molecules designed to inhibit the function of Aurora kinases. By blocking these kinases, these inhibitors can halt cell division, making them potential therapeutic agents in cancer treatment. These inhibitors can be specific to Aurora A, Aurora B, or both, depending on their design and target specificity.
